Literature DB >> 18398049

Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk.

Jennifer Brooks1, Roy E Shore, Anne Zeleniuch-Jacquotte, Diane Currie, Yelena Afanasyeva, Karen L Koenig, Alan A Arslan, Paolo Toniolo, Isaac Wirgin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18398049     DOI： 10.1158/1055-9965.EPI-08-0065

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  21 in total

1.  Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.

Authors:  Xiao-Feng He; Wu Wei; Jiao Su; Zi-Xuan Yang; Yi Liu; Ying Zhang; Da-Peng Ding; Wei Wang
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

2.  Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.

Authors:  Bin Kong; Zhi-Dong Lv; Li Chen; Ruo-Wu Shen; Li-Ying Jin; Zhao-Chuan Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  The Arg188His polymorphism in the XRCC2 gene and the risk of cancer.

Authors:  Yonggang Zhang; Haichuan Wang; Yuanling Peng; Yuqi Liu; Tianyuan Xiong; Pei Xue; Liang Du
Journal:  Tumour Biol       Date:  2014-01-12

5.  Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population.

Authors:  Ranbir Chander Sobti; Saranjeet Kaur; Vijay Lakshmi Sharma; Shrawan Kumar Singh; Seyed Ali Hosseini; Rupinder Kler
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

6.  Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer.

Authors:  Renata Talar-Wojnarowska; Anita Gąsiorowska; Marek Olakowski; Daria Dranka-Bojarowska; Paweł Lampe; Beata Smolarz; Ewa Małecka-Panas
Journal:  Biomed Rep       Date:  2015-12-02

7.  Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey.

Authors:  Ilhami Gok; Meryem Baday; Suleyman Cetinkunar; Kemal Kilic; Bulent Caglar Bilgin
Journal:  Bosn J Basic Med Sci       Date:  2014-09-13       Impact factor: 3.363

8.  Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis.

Authors:  Karen Curtin; Wei-Yu Lin; Rina George; Mark Katory; Jennifer Shorto; Lisa A Cannon-Albright; Gillian Smith; D Timothy Bishop; Angela Cox; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

9.  Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.

Authors:  Kai Yuan; Meiling Huo; Yong Sun; Hongyan Wu; Hongqiang Chen; Yulong Wang; Rongzhan Fu
Journal:  Tumour Biol       Date:  2015-08-12

10.  RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.

Authors:  Deepa Sekhar; Singh Pooja; Sandeep Kumar; Singh Rajender
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.